Der er forekommet reaktivering af hepatitis B hos patienter, der modtog TNF- antagonister inkluderende Trudexa, som er kroniske bærere af denne virus.
Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Trudexa, who are chronic carriers of this virus.